OPRX OptimizeRx Corp: Total Debt to Equity Ratio

OptimizeRx Corporation (OPRX) revenues rely on pharmaceutical company advertising budgets, with success depending on the software's integration with patient maps. The business has established a robust electronic prescription network, creating significant switching costs for clients. The company is currently consolidating acquired IT assets into a unified environment. This daily price chart reflects that the individual debt-to-equity ratio stands at 0.15.

This ratio measures the proportion of debt financing relative to equity, determining the issuer's degree of financial autonomy. The metric reveals the business's dependence on creditors, which is critical for assessing balance sheet stability. For the OptimizeRx (OPRX) digital platform, which maintains minimal physical assets, this parameter reflects the efficiency of its IT infrastructure scaling. By analyzing the historical debt-to-equity ratio, an investor can discern the actual debt load, allowing for a balanced assessment of the asset's risk profile within a portfolio.